Skip to main content
FinSpry Logo
FinSpry
NEO logo
NEO
(NASDAQ)
NeoGenomics, Inc.
$8.39-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NeoGenomics (NEO) Stock Price & Financial Analysis

NeoGenomics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.20 - $8.61
52-Week High$13.74
52-Week Low$4.72
Open$8.37
Volume1.21M
Average Volume (3M)2.32M
Market Cap1.08B
Shares Outstanding129.17M
Price to Sales (P/S)1.43
Price to Book (P/B)1.28
EV/EBITDA-37.61
Revenue (TTM)745.97M
Net Income (TTM)-99.21M
Free Cash Flow (TTM)-5.09M
EPS (TTM)$-0.96
Profit Margin-13.30%
Operating Margin-11.26%
Return on Equity (ROE)-11.97%
Debt to Equity0.41
50-Day MA$8.36
200-Day MA$9.50
52-Week Change1.76%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateDec 17, 2020

Frequently Asked Questions About NeoGenomics

What is the current stock price for NEO?

As of the latest trading session, NEO stock trades at $8.39. The 52-week range is $4.72–$13.74, with a day range of $8.20–$8.61.

What is the P/E ratio for NEO?

The P/E ratio (Price-to-Earnings) for NEO is shown in the Key Statistics section. This valuation metric helps compare NeoGenomics, Inc. to industry peers.

Does NEO pay dividends?

NeoGenomics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NEO?

Based on 4 analysts, the consensus for NEO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NEO?

NeoGenomics's market capitalization is $1.08B, classifying it as a small-cap company. NeoGenomics operates in the Healthcare sector within the Diagnostics & Research industry.